Extracellular Vesicles Derived From Ex Vivo Expanded Regulatory T Cells Modulate In Vitro and In Vivo Inflammation

Extracellular vehicles (EVs) are efficient biomarkers of disease and participate in disease pathogenesis; however, their use as clinical therapies to modify disease outcomes remains to be determined. Cell-based immune therapies, including regulatory T cells (Tregs), are currently being clinically ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Thome, Aaron D., Thonhoff, Jason R., Zhao, Weihua, Faridar, Alireza, Wang, Jinghong, Beers, David R., Appel, Stanley H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258040/
https://www.ncbi.nlm.nih.gov/pubmed/35812435
http://dx.doi.org/10.3389/fimmu.2022.875825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258040/
https://www.ncbi.nlm.nih.gov/pubmed/35812435
http://dx.doi.org/10.3389/fimmu.2022.875825

Ejemplares similares